Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Analysis: Japan’s Drug Makers See Price Cuts Under U.S. Democrat

This article was originally published in PharmAsia News

Executive Summary

Japan's drug makers can expect to be affected by the presidential election in the United States in November, according to analysts. One element that cannot be avoided regardless of the party in the White House is the fact generics will spread through the U.S. market as patents on Japanese drugs and others expire. Overall, however, because Democrats tend to favor government guarantees for health care, there will be a pressure to keep drug prices down. Analysts cite statistics of slow pharmaceutical price growth under previous Democratic administrations, faster growth under Republicans. (Click here for more - a subscription may be required



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts